← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksSURGRevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

SURG logoSurgePays, Inc. (SURG) Revenue History

Annual and quarterly revenue from 2013 to 2024

TTM Revenue
$50.4M
vs. $137.1M LY
YoY Growth
+291.6%
Excellent
Latest Quarter
$18.7M
Q3 2025
QoQ Growth
+62.2%
Excellent

Compound Annual Growth Rate (CAGR)

3-Year+6.0%Solid
5-Year+18.8%Strong
10-Year+36.7%Excellent
Highest Annual Revenue$137.1M (2023)
Highest Quarter$36.2M (Q4 2022)
Revenue per Share$2.63
Revenue per Employee$387K

Loading revenue history...

SURG Revenue Growth

1-Year Growth
+291.6%
Excellent
3-Year CAGR
+6.0%
Solid
5-Year CAGR
+18.8%
Strong
10-Year CAGR
+36.7%
Excellent
TTM vs Prior Year$86.8M (-63.3%)
Revenue per Share$2.63
Revenue per Employee$387,481.185
Peak Annual Revenue$137.1M (2023)

Revenue Breakdown (FY 2023)

SURG's revenue distribution by segment and geography for fiscal year 2023

By Product/Segment

Lead Generation100.0%

By Geography

Other100.0%

Download Historical Data

12 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

SURG Revenue Analysis (2013–2024)

As of May 8, 2026, SurgePays, Inc. (SURG) generated trailing twelve-month (TTM) revenue of $50.4 million, reflecting explosive growth of +291.6% year-over-year. The most recent quarter (Q3 2025) recorded $18.7 million in revenue, up 62.2% sequentially.

Looking at the longer-term picture, SURG's 5-year compound annual growth rate (CAGR) stands at +18.8%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $137.1 million in 2023.

Revenue diversification analysis shows SURG's business is primarily driven by Lead Generation (100%). With over half of revenue concentrated in Lead Generation, the company maintains significant focus in this area while developing other growth vectors.

When compared to Technology sector peers including LQDT (+9.3% YoY), GSAT (+8.5% YoY), and SSTK (-1.8% YoY), SURG has outperformed the peer group in terms of revenue growth. Compare SURG vs LQDT →

SURG Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
SURG logoSURGCurrent$50M+291.6%+18.8%-68.6%
LQDT logoLQDT$477M+9.3%+18.3%7.4%
GSAT logoGSAT$250M+8.5%+13.7%-0.4%
SSTK logoSSTK$990M-1.8%+8.2%11.1%
TMUS logoTMUS$88.3B+9.5%+5.2%21.2%
Best in groupLowest in group

SURG Historical Revenue Data (2013–2024)

Showing 10 of 12 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2024$60.9M-55.6%$-14,324,199-23.5%$-41,782,351-68.6%
2023$137.1M+12.8%$35.6M26.0%$18.9M13.8%
2022$121.5M+138.0%$13.5M11.1%$634K0.5%
2021$51.1M-6.2%$6.2M12.1%$-5,992,568-11.7%
2020$54.4M+111.3%$2.5M4.5%$-10,145,668-18.6%
2019$25.7M+68.9%$3.1M12.1%$-7,768,028-30.2%
2018$15.2M+966.1%$6.7M43.8%$-1,535,469-10.1%
2017$1.4M-56.6%$697K48.7%$-2,069,070-144.7%
2016$3.3M+16.4%$968K29.4%$-3,106,814-94.2%
2015$2.8M+5.9%$501K17.7%$-1,320,967-46.6%

See SURG's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is SURG Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare SURG vs NVDA

Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.

Start Comparison

SURG — Frequently Asked Questions

Quick answers to the most common questions about buying SURG stock.

Is SURG's revenue growth accelerating or slowing?

SURG revenue is accelerating at +291.6% year-over-year, exceeding the 5-year CAGR of +18.8%. TTM revenue reached $50M. Growth momentum has increased versus prior periods.

What is SURG's long-term revenue growth rate?

SurgePays, Inc.'s 5-year revenue CAGR of +18.8% reflects the sustained expansion pattern. Current YoY growth of +291.6% is above this long-term average.

How is SURG's revenue distributed by segment?

SURG reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

SURG Revenue Over Time (2013–2024)